Company profile

ステラファーマ株式会社

EDINET
E35496
Securities
4888
Industry
Pharmaceutical
Industry Peer Ranking
View Company Rankings
Latest annual securities report
2026-06-23 Annual Securities Report PDF HTML
Latest financial report
2026-11-13 Semiannual Securities Report PDF HTML
Latest filing
—

Industry position

Pharmaceutical

View details
Profitability Weak Current Bottom 19% 5-year trend Broadly stable
Financial strength Below average Based on Equity ratio Current Bottom 34% 5-year trend Broadly stable
Growth Average Current Bottom 48% 5-year trend Improving
Cash generation Weak Current Bottom 13% 5-year trend Broadly stable

Latest half-year results

H1 FY2027

2026/04/01 - 2026/09/30

Standalone · Japanese GAAP · Cumulative YTD

For H1 FY2027, revenue was ¥175.17 million, down 12.5% year over year. Operating income was -¥498.08 million, down 66.6% year over year. Net income was -¥469.19 million, down 52.4% year over year.

Revenue ¥175.17M down 12.5% year over year
Operating income -¥498.08M down 66.6% year over year
Net income -¥469.19M down 52.4% year over year
Operating cash flow -¥423.92M
Free cash flow -¥430.89M
Total assets ¥5.52B

Half-year trend

Half-year financial trend

H1 values are cumulative year-to-date.

H2 values are calculated when comparable.

Standalone · Japanese GAAP · Cumulative YTD

Mode

Half-year financial data

Annual key financial indicators

FY2026

Standalone Japanese GAAP

Revenue reached ¥323.39 million, down 66.4% year over year. Operating income was -¥748.96 million. Operating margin was -231.6%. Net income was -¥780.92 million. ROE was -27.7%; equity ratio was 54.1%; free cash flow was -¥350.19 million.

Revenue ¥323.39M down 66.4% year over year
Operating income -¥748.96M
Net income -¥780.92M
Total assets¥4.49B
Total equity—
Operating cash flow-¥334.51M
Free cash flow-¥350.19M

Industry position details

Pharmaceutical

Annual data for the same fiscal year and industry

Comparison sample varies by metric

Profitability Weak

Operating margin Bottom 89% / ROE Bottom 80%

Financial strength Below average
Based on Equity ratio

Equity ratio Bottom 68%

Growth Average

Revenue growth Bottom 97% / 3-year revenue CAGR Top 16%

Cash generation Weak

Operating cash flow margin Bottom 89% / Free cash flow margin Bottom 91%

Profitability Industry position history Broadly stable
2026 Bottom 19% 2025 Bottom 44% 2024 Bottom 28% 2023 Bottom 26% 2022 Bottom 15%
Financial strength Industry position history Broadly stable
2026 Bottom 34% 2025 Bottom 35% 2024 Bottom 37% 2023 Bottom 37% 2022 Bottom 41%
Growth Industry position history Improving
2026 Bottom 48% 2025 Top 4% 2024 Top 20% 2023 Top 3% 2022 Bottom 6%
Cash generation Industry position history Broadly stable
2026 Bottom 13% 2025 Top 15% 2024 Bottom 18% 2023 Bottom 23% 2022 Bottom 9%
Profitability Operating margin -231.6% Industry median 6.9% Bottom 89% Comparison sample 42
Profitability ROE -27.7% Industry median 3.8% Bottom 80% Comparison sample 48
Financial strength Equity ratio 54.1% Industry median 68.3% Bottom 68% Comparison sample 50
Growth Revenue growth -66.4% Industry median +4.2% Bottom 97% Comparison sample 31
Growth 3-year revenue CAGR +12.2% Industry median +5.2% Top 16% Comparison sample 26
Cash generation Operating cash flow margin -103.4% Industry median 7.4% Bottom 89% Comparison sample 43
Cash generation Free cash flow margin -108.3% Industry median -0.6% Bottom 91% Comparison sample 43

Annual financial data

Implied share price and market capitalization are estimated from EDINET filing data, not real-time market prices.

Fiscal year Scope Accounting standard Revenue Operating income Ordinary income Profit before tax Net income Profit attributable to owners of parent Comprehensive income Total assets Total liabilities Net assets Shareholders' equity Equity Equity attributable to owners of parent Equity for ratio Operating cash flow Investing cash flow Financing cash flow Free cash flow Cash and cash equivalents Basic EPS P/E Implied Share Price Implied Market Capitalization Book value per share Dividend per share Shares issued Equity ratio Official equity ratio ROE ROA Operating margin Ordinary income margin Net margin Operating cash flow margin Free cash flow margin Dividend payout ratio Revenue YoY Operating income YoY Ordinary income YoY Profit before tax YoY Net income YoY Total assets YoY Equity YoY Operating cash flow YoY Investing cash flow YoY Financing cash flow YoY Free cash flow YoY Cash and cash equivalents YoY EPS YoY Dividend per share YoY Shares issued YoY Employees YoY Average salary YoY Employees Average salary
FY2026 Standalone Japanese GAAP 323389000 -748957000 -778005000 -778005000 -780917000 4486694000 2060126000 2426568000 2426568000 2426568000 -334514000 -15671000 -33279000 -350185000 2778006000 -22.95 71.33 3.40341E+7 0.5408365269 0.5408 -0.2772132247 -0.1740517628 -2.315963128 -2.4057868388 -1.0344012938 -1.0828599612 -0.6635073013 -4.6430742226 -4.6430742226 -0.1717541328 -0.2434670778 -3.3824425959 -1.0544934209 -1.046140536 -1.81821984 -0.1212932208 -4.4383886256 0.0 0.0930232558 0.0231059465 47 6630190
FY2025 Standalone Japanese GAAP 961058000 -90246000 -137869000 -137869000 -140811000 5417104000 2209619000 3207485000 3207485000 3207485000 140408000 287576000 721253000 427984000 3161471000 -4.22 94.26 3.40341E+7 0.5921032714 0.5921 -0.0504292508 -0.0259937782 -0.0939027613 -0.1434554418 0.1460973219 0.4453258804 2.5661970159 0.8186430556 0.8188260865 0.4178591863 0.3493768647 1.160130104 32.9174250832 2.1585002168 1.4831353496 0.5711257096 0.8288726683 0.0899457174 -0.0227272727 -0.0259961199 43 6480453
FY2024 Standalone Japanese GAAP 269491000 -760300000 -760208000 -760976000 -763749000 3820622000 1443610000 2377012000 2370053000 2377012000 -876837000 -9010000 228353000 -885847000 2012233000 -24.66 75.9 3.12255E+7 0.6221531468 0.6203 -0.2977861061 -0.1999017437 -2.8212444943 -2.8209031099 -3.2536782304 -3.287111629 0.1764723858 0.0203176911 0.0193279672 -0.1174462406 -0.1364177029 -0.0594053903 0.6989139515 -0.2174841254 -0.0329444935 -0.2462776157 0.085650723 0.0420205364 -0.0434782609 -0.0398925463 44 6653416
FY2023 Standalone Japanese GAAP 229067000 -806775000 -775974000 -775974000 -778824000 4329053000 1576550000 2752502000 2742357000 2752502000 -827669000 -29925000 291819000 -857594000 2669727000 -26.97 91.51 2.99663E+7 0.6358208135 0.6335 -0.2670806953 -0.1799063213 -3.522004479 -3.3875416363 -3.6132179668 -3.7438566009 1.2884730659 -0.0155557999 -0.0155557999 -0.082565158 -0.1062211186 0.2344401084 0.9146370685 -0.9237919274 0.4009922532 -0.1748646732 0.0135332846 0.0449921712 0.0697674419 -0.0048216105 46 6929866
FY2022 Standalone Japanese GAAP 100096000 -741902000 -764088000 -764088000 -767719000 4718649000 1639026000 3079623000 3079623000 3079623000 -1081129000 -350562000 3829240000 -1431691000 3235502000 -27.34 107.39 2.86761E+7 0.652649307 0.6526 -0.4638307655 -0.1626988996 -7.4119045716 -7.6335517903 -10.8009211157 -14.3031789482 -0.5140215956 -0.1640726883 -0.1640726883 1.3034384757 12.3479962552 -0.3989565366 -14.3324877537 12.5199066191 -0.7993414397 2.8612020736 0.1689969605 0.4240219691 0.0 0.0273675871 43 6963441
FY2021 Standalone Japanese GAAP 205968000 -680567000 -656392000 -656392000 -659244000 2048524000 1817805000 230718000 230718000 230718000 -772811000 -22864000 -332402000 -795675000 837952000 -32.9 11.46 2.01374E+7 0.1126264569 0.1126 -1.4319702069 -0.3218141452 -3.3042365804 -3.1868639789 -3.7520925581 -3.8631000932 0.3157957828 0.3157957828 -0.2298799326 0.1540878059 -1.0146753188 -3.8469939777 -2.2347398461 43 6777945
FY2020 Standalone Japanese GAAP
FY2019 Standalone Japanese GAAP
FY2018 Standalone Japanese GAAP
FY2017 Standalone Japanese GAAP

Source filings

Select a document type to load the filings list.

Select a filing type to load the list.

Document filter

Select filing types

Choose the filing types to display.

Filing types containing financial data are selected by default.

Source: FSA EDINET / Data and metrics: bestforever.jp
New EDINET filings are typically imported within minutes, with financial data and analysis results updated accordingly.